Cristen Callan

Associate, New York

Biography

Overview

Cristen is an associate in the Mergers & Acquisitions Practice Group, and is a resident in the New York office. Ms. Callan represents corporate clients and private equity funds in domestic and global mergers, acquisitions and equity investments in a broad range of industries. Ms. Callan has also worked on commercial litigation matters.

Bars and Courts
New York
US District Court for the Southern District of New York
Education
JD
Hofstra University
BA
Boston College
Languages
English

Experience

Recent matters include:

  • Representation of Golden Nugget Online Gaming, Inc. and the Special Committee of its Board of Directors in its all-stock acquisition by DraftKings, Inc., a digital sports entertainment and gaming company.
  • Representation of Ara Partners in its acquisition of 100% of the shares of Petainer UK Holdings Ltd., a responsible manufacturing business that offers a wide range of lightweight, sustainable PET packaging solutions with over 35 years of experience designing and manufacturing high-quality and cost-efficient products, from Petainer Investment Ltd., indirectly owned by KKR Credit.
  • Representation of ABM Industries in its acquisition of RavenVolt for an initial purchase price of US$170 million in cash at closing, plus the potential for post-closing earn-out consideration payable in cash in calendar years 2024, 2025, and 2026, if the RavenVolt business achieves certain financial metrics in calendar years 2023, 2024 and 2025.
  • Representation of Cobepa SA, a private equity investor based in Belgium with over €4.2 billion net asset value, on its acquisition of Ned Stevens, one of the leading gutter cleaning services providers in the US.
  • Representation of Biosynex S.A., a French biotechnology société anonyme, on its US$17.2 million acquisition of Chembio Diagnostics, Inc., a U.S. biotechnology corporation.
  • Representation of Soaring Eagle Acquisition Corp., a special acquisition company, in its $15 billion business combination with Ginkgo Bioworks, Inc., a synthetic bio-tech company.